Biosynthesis and secretion of salusin-α from human cells

    loading  Checking for direct PDF access through Ovid


Salusins originally identified using bioinformatics analyses have been shown to act on the cardiovascular and endocrine systems. Although the hypotensive activity of salusin-α is limited, it exerts a significant anti-atherosclerotic effect via suppression of foam cell formation in human monocyte-derived macrophages by down-regulating acyl-CoA:cholesterol acyltransferase-1. Furthermore, serum salusin-α levels show a close negative correlation with the severity of atherosclerotic diseases. However, biosynthesis and secretion of salusin-α peptide from cultured mammalian cells have not been demonstrated to date. We examined the expression, synthesis and release of salusin-α in human-derived cell lines. Preprosalusin mRNA and protein were detected ubiquitously in all cells tested, whereas the processing of preprosalusin into salusin-α peptide is dependent upon each cell type. Immunohistochemical study revealed the most abundant salusin-α-like immunoreactivity to be present in HeLa cells which released salusin-α-like immunoreactivity into the culture supernatant. Analysis of extracted conditioned media from HeLa cells by reverse-phase high performance liquid chromatography coupled with radioimmunoassay detection revealed a single immunoreactive component that co-eluted with authentic salusin-α. These results present the first evidence that salusin-α is biosynthesized and released from human-derived cells.

Related Topics

    loading  Loading Related Articles